We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

37 hedge funds and large institutions have $66.5M invested in Sinovac Biotech, Ltd in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $62.6M → $66.5M (+$3.95M)

8% less funds holding

Funds holding: 40 → 37 (-3)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
13
Closed
7
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$89K

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$3.19M
2
Renaissance Technologies
Renaissance Technologies
New York
+$407K
3
FIM
Freedom Investment Management
Connecticut
+$241K
4
PIM
Platinum Investment Management
Australia
+$161K
5
BFA
BlackRock Fund Advisors
California
+$127K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.65M
2
Citadel Advisors
Citadel Advisors
Florida
-$539K
3
Goldman Sachs
Goldman Sachs
New York
-$296K
4
Morgan Stanley
Morgan Stanley
New York
-$167K
5
BIT
BlackRock Institutional Trust
California
-$121K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
26
PNC Financial Services Group
Pennsylvania
$39K – – –
UBS Group
27
UBS Group
Switzerland
$29K -$11.2K -2,115 -28%
AIG
28
American International Group
New York
$24.7K +$528 +100 +2%
Wells Fargo
29
Wells Fargo
California
$7K -$21.6K -4,080 -77%
GWM
30
Gupta Wealth Management
California
$3K – – –
Group One Trading
31
Group One Trading
Illinois
$2K -$70.1K -13,264 -98%
LTFS
32
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Walleye Trading
33
Walleye Trading
New York
$2K +$2.11K +400 New
WA
34
WFG Advisors
Texas
$1K – – –
Bank of America
35
Bank of America
North Carolina
$1K +$1.3K +247 New
Citadel Advisors
36
Citadel Advisors
Florida
– -$539K -108,652 Closed
BIT
37
BlackRock Institutional Trust
California
– -$121K -24,460 Closed
NCCM
38
Nine Chapters Capital Management
New Jersey
– -$68K -13,800 Closed
SCM
39
Stevens Capital Management
Pennsylvania
– -$53K -10,639 Closed
Barclays
40
Barclays
United Kingdom
– -$20.3K -3,836 -98%
TRCT
41
Tower Research Capital (TRC)
New York
– -$12K -2,589 Closed
US Bancorp
42
US Bancorp
Minnesota
– -$7K -1,500 Closed
MFS
43
MSI Financial Services
Massachusetts
– -$4.81K -911 -91%
1
2

SVA Hedge Fund Activity: Q2 2015 in Review

37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q2 2015, worth a combined $66.5M — up 6.3% from $62.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SVA and 5 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 10 added.

The largest buyer was First Manhattan, opening a new position worth an estimated $3.19M. The largest seller was Wellington Management Group, cutting an estimated $2.65M.

  • 37 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q2 2015, down from 40 in Q1 2015.
  • Funds reported $66.5M of Sinovac Biotech, Ltd stock for Q2 2015, up 6.3% quarter-over-quarter.
  • 5 funds opened new Sinovac Biotech, Ltd positions in Q2 2015 and 7 closed out, a net change of -2 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q2 2015 was First Manhattan, an estimated $3.19M added.
  • The largest Sinovac Biotech, Ltd seller in Q2 2015 was Wellington Management Group, an estimated $2.65M sold.

Based on aggregated 13F filings for Q2 2015.